Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'll take 2s ...
The insider buying only goes so far, the stink on this is still strong. A guy will be able to buy this in the 2’s yet….
They keep on buying their own stock, hence ... I'm doing the same
BRTX: Share Structure
Authorized Shares
75,000,000
12/06/2021
Outstanding Shares
3,637,219
05/09/2022
Restricted
309,173
12/06/2021
Unrestricted
3,206,602
12/06/2021
-- First Site Will Enroll First Patient in the Clinical Study--
MELVILLE, NY., June 13, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced site initiation for its Phase 2 clinical trial targeting chronic lumbar disc disease (cLDD). The Denver Spine and Pain Institute is the first clinical site to be initiated. Additional selected sites are expected to be initiated in 2022.
BioRestorative’s Phase 2 trial is a double-blind controlled, randomized study to evaluate the safety and preliminary efficacy of a single dose intradiscal injection of the Company’s autologous investigational stem cell-based therapeutic, BRTX-100. A total of up to 99 eligible patients will be randomized at up to 15 centers in the United States to receive either the investigational drug (BRTX-100) or control in a 2:1 fashion.
“Currently there are no approved, cell-based therapies for cLDD. While there is encouraging data that suggests that patients with cLDD could benefit from autologous stem cell transplants, the low oxygen micro-environment of the disc makes cell-based therapies challenging. BRTX-100 is manufactured under low oxygen conditions and engineered to survive this environment,” said Scott Bainbridge, M.D., Principal Investigator for the BRTX-100 trial at The Denver Spine and Pain Institute. “Positive proof-of-concept data in this trial could be disruptive and support the potential applicability of BRTX-100 to other spine and musculoskeletal disorders where low oxygen micro-environments are found.”
“We are pleased to initiate the first of several sites across the United States that will be enrolling for the trial,” said Lance Alstodt, Chief Executive Officer of BioRestorative Therapies. “Our sites have been carefully reviewed and selected and have clinical expertise in treating patients who could potentially benefit from BRTX-100. We look forward to working with the principal investigators and their clinical trial teams.”
About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. (www.biorestorative.com) develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Our two core programs, as described below, relate to the treatment of disc/spine disease and metabolic disorders:
Disc/Spine Program (brtxDISC™): Our lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow. We intend that the product will be used for the non-surgical treatment of painful lumbosacral disc disorders or as a complementary therapeutic to a surgical procedure. The BRTX-100 production process utilizes proprietary technology and involves collecting a patient’s bone marrow, isolating and culturing stem cells from the bone marrow and cryopreserving the cells. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient’s damaged disc. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. Pursuant to authorization received from the Food and Drug Administration, we have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease.
Metabolic Program (ThermoStem®): We are developing a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (“BAT”). BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research indicates that increased amounts of brown fat in animals may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including, without limitation, those set forth in the Company's latest Form 10-K filed with the Securities and Exchange Commission and other public filings. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.
CONTACT:
Email: ir@biorestorative.com
You are not alone.
This is exactly why I added in the 3.5 to 4.4 range. Easy 15 to 25% gain for a part of my position.
I do think this is one for the long run.
Did more digging. Found out that Broadrick has more than the 280K shares. Via a holding he owns for 93% he has an extra 300K. This puts him around 600K shares, which represent over 20% of the float.
I don't think you'll keep on buying to get noticed, if you own already this amount.
On top other insiders are buying.
Anyhow, I'm in since close to 2 years. Had accumulated some free shares and am now adding. I don't mind the wait.
Maybe so folks will notice and conclude "they must know something?"
I don't expect there'll be any sort of OTC-ish run for this stock anymore, and have been surprised that they haven't PR'd the heck out of movement towards the trial this "uplisting" was supposed to kick off, if for no other purpose than to sell Auctus's stock. The consideration of trial locations barely got any interest. Auctus will sell and be an anchor if they do kick up some volume, just not sure what it will take.
I know, still, why would you buy as an insider if you don't hope to win out of this ?
Don't forget that Auctus has about 1.6M shares looming to sell once they can break even (upper $5) or profit. They're not allowed to convert more than what would put them over 5% of the O/S at any time, but I expect they'll sell into any sort of good news that gets them profit.
$BRTX
3.64 million OS
2.9 million float
Market cap 13.89 million
Insiders bought since November 2021 (post reverse split) 278000 shares for 1.472 million (avg of $5.3/share). We know as well that Dale Broadrick is already owning 10% of the shares sinces November. This means that + 19% is owned by insiders. Why would they keep on buying ? :)
https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001505497
What's new here let's get the pps under $3 or lower so the original here can make up some Shares
Go BRTX Go
Over $1.2 million bought by insiders since January, nothing sold
Exactly my plan as well :)
Yes something usually happens when insiders keep buying...the clinical trials for the BRTX-100 are under way..according to plan...expecting great results of course..and the ThermoStem going into clinical stage one trials Before years EOY..would get this to 10-$20 pps..IMO..the patents will work out..and as long as Silva stays with LA/BRTX..We will have the top Stem Cell Company/stock on the planet.IMO.We wait..buy on Dips..and Wait for the rewards..Have to!
Insiders keep on adding ... today a silly 200 by Lance ... you're not going to tell me you buy if you don't expect a return as an insider. So ... something will happen and I guess it will be sooner rather than later.
Yes..We will sweat it out..for years ..but I believe we have a Blue Chip Company with 2 patents that could be life changing..for Me and You..My price to sell is between $50 and $100 per share..hope I am Alive to enjoy a little of it....IMO..We will get there as the trials of the 2 patents prove the tech to be life changing..FDA approved ..In meantime we add on dips ..and wait.watch.and enjoy the Ride..
You are correct.
Insiders keep on buying in the open market. So something must be brewing.
Added 3.5 last week ... So I'm still here as well with a substantial loss. Now, you only have a loss when you sell ... so I'll sweat it out.
Have we hit Bottom Yet?? ..My Friend Got disgusted and sold all of his $240,000 dollars in BRTX with a loss of $210,000..He is not talking to Me anymore.A Lifelong Best Friend Blames Me and LA for his Loss..He could have sold when it was a penny and went to .047 and made money.I could have sold and made $210,000 in profit but I held because of being stupid and Greedy..costly mistakes..Now Ihave to hold for ?? Years with my 2,000 shares..LOL.but I wont sell.I bought most of my shares at .0022 so im not taking a loss..LA screwed us with a 4000-1 RS.We know that we have to hold/or buy more now at this low pps..and wait till it runs ..2-5 years ? Im holding but I still believe company is going to lead the Stem Cell World to Greatness.IMO $50 in 2 years if both patents are doing great in Clinical trials..Then who knows..I will get a profit someday that I believe 100% to be true.Buying more next month if pps is this low..got to make up on the other end in
NASDAQ..LOL..Happy Memorial Powerstreet and Declaes and All !
Let's go BRTX L/A do your Magic and drive the price under $2 I know you can do it just give us more of your lies.
Go BRTX Go
Lance bought more shares.
Does anyone know why the late buying surge today? It was a surprise! Was it more insiders buying or does someone know good results is close at hand or just speculation?
There nothing here but stories of greatness that seem to never happen for BRTX. LA only care about himself and The Frisco kid
They are lining there pockets
LIES,LIES,LIES
GLTA
Nothing about "fixin' to get ready to prepare to consider to do" the phase 2 trials seems to be moving the needle for Auctus to sell their shares. Maybe they should consider actually doing that trial.
$BRTX should bounce from here
Any news going on here with BRTX
Well LA you got anything
Well, again ..., insiders keep on buying.
You're not going to tell me you would do that if you know this company was worth nothing ...
I talked to him after the Horrible 4000-1 RS was shockingly apllied..crushing the loyal investors that founded the company..Was such a RS necessary..especially when he could have pumped up the price with some positive news/catalyst..??Why not get the pps up to .015 cents then do it alot less..1000-1 would have been much better..but he crushed us longs..now We longer and longer..Well hopefully he will get these patents into trials with great results in the next few years..Maybe we can get a profit eventually ...and not screw us again ..I dont trust any CEO..I like LA and believe in the two patents if Francisco Silva stays on..This Ticker will ..can be a $40 buck plus stock..so I buy maybe another $5K and im done for the next few years..The Plan..
A week after he did the RS..He Seemed confifent that holding Long Term now will get you rewarded..but to get a $200 Grand profit again..Im looking at 5 years with the ThermoStem being the Big time pps Changer..I wait and cash out at 100K profit or lose it All..I was stupid and greedy..and LA dropped the
Bomb on us loyal shareholders.Now lets say I believe it will take 2 years to get to $40-50 bucks oer share with two patents in clinical trilas..Revenue could be Huge if both patents make it thru clinical trials with great results..then to produce revenue..I do believe that LA and Francisco will acheive Huge Financial success for themselves..LOl..and hopefully to us Longs..for Newbees..its a undervalued stgock with huge potemcial..in NasDaq...hitting 40 bucks a share will take a few years but I believe BRTX will get there..Im buying next week ..maybe ill cash in on the Nasdaq side to offset my OTC Screwup of not to sell..Im in the Lithium market now..LOL..
Can I ask when you talked to them ?
Yes I Agree with You 100%..I talked to LA for 40 minutes..and I really like what he presented to me on the companys assets..along with have Francisco Silva staying on with the company! Silva Stays..I Stay..But ..I will never know why He did what he did..a 4000-1 Split to US Long Shareholders??? In my mine..LA could have PRd the company up to at least a .013 PPS..To reduce the pain of the 4000-1 RS..We Got Screwed ..I singned for it ..in the vote..but Never did I ever Think that LA would wiped us out ..But As long as Silva stays on thru both trials of the two patents?? ..I will keep buying more shares ..at this pps of $4.05..buying another thousand or approx ..250 more shares next wednesday..I hope I live to see the companys success with these two patents..I have to try to profit in Nasdac..cause I got greedy and did not sell in OTC..Wont happen again..Im getting old..Need to live to see BRTX Glory..and for LA to Redeem Himself to the Loyal longs Left Holding whats left behind..But Its time to Buy if you Believe in the TECH..and I Do! Its works..must wait up to 2-5 years?? We will see.Go BRTX!
This Company is Crap LA only take of his self and friends and family that are buying BRTX He will screw everyone else. He a A Hole screwed all the old shareholder's with his Unannounced split Giving nobody a chance to get out before they dump the shares 4000 to 1 reverse split
Go BRTX
Anyone here check this out
SONN up 60% today on FDA approved of it's brand
Go BRTX Go
Right on ... I've been adding as well
Just 2 more days for the lockup to end, then Auctus will be free to sell stock, though they're limited to less than 5% of the O/S at a time. They need $5.50 or so to get their money out and would still have warrants, so seems like they'll cap the PPS for awhile if some buying is stirred up by progress on the trial by selling into it.
Hi Declaes....Well I am adding another 500 shares tomorrow..Got to make money on ..IMHO..A very undervalued Gem to Be..or not to Be..LA and Francisco are quiet at the Hel..Good News will come withing a few months..IMO..so add more shares at this pps..Only way to make it somewhat right afterinsane 4000-1 RS..Still shaking my head on not selling back in Sept 2020 for a nice $220 K Profit..I got Greedy! and Got Played..after I had the Play! LOL..A Long haul in waiting here..in 5 years ..I will be 70..need that boat! LOL..Until then..We Waitand buy at this level..Seems nSmart.I agree with your logic..TTYA Soon God Willing we will enjoy BRTX Money someday ..2-5 years.IMO..
This should ni trade under $9 imo . But then I have been wrong along on the stock. Longterm hold an add if you can imo
On March 9th, the lockup period on Auctus's shares will end and they'll be allowed to sell. They're still limited to less than 5% of the O/S at a time when converting those Preferred A shares they got in exchange for their debt and warrants. To cover the loans they made during the process, the PPS has to stay above $5.40, so they'll ease them in. When/if the company announces the actual launch of the trial it may kick up some decent liquidity for them to sell into. It'll be an anchor for awhile, they have a bit over 1.5M shares into an O/S of 3.5M.
They also have warrants, but they have a strike price of $10.
Profitability is not just about whether it works. Many things “work” but can’t be sold profitably because they would be too expensive for most consumers. That has always been the problem with BRTX and they have detailed it extensively in their past financial reports. Even though their disc protocol likely works for at least a subset of spine patients, there is a likelihood it will still be financially unsuccessful because insurance and Medicare will not reimburse enough for them to recoup the high manufacturing and compliance costs. That’s why the Regenexx doctors sold the rights to it. Add to that competition from other therapies in development, and unregulated, same-day BMAC stem cell procedures that are already available, and BRTX-100 has a highly uncertain financial future even if it works. If they’re going to make money, it’s more likely to be with the brown fat product.
We all would like tomknow whats going on with the ThermoStem Patents approved for usage/? applications.. in Japan,Israel, and Australia..This patent could be a huge game changer..for BRTX..What is going on with it in these 3 countries now is the question..and when is the intended clinical phase 1 trials for ThermoStem going to start?LA has stated before the end of 2022???? We need some updates on these matters..IMO.
It's probably a friend or family member of L/A He or ly takes care of his friends and family
Go BRTX Go
Well, someone likes the news today.
Nice $70,000 ask slap at $4.38 on 16,000 shares. That's 64M pre-split for anyone doing the math...LOL
Yep a 1-for-4,000 R/S it was a slaughter
Go BRTX Go
Wow didn’t know this uplisted. Sorry haven’t been paying attention as I sold a while ago did they do a rs?
You hit it right on point We got The butchered It was like a slaughter house we all know what LA Past life was He he was the butcher of Bakersfield.
Like I said they are not getting and think for me till they bounce under $2.00 and it will happen why because they have no volume because there's no trust after what LA did
Go BRTX Go
I fell in love with BRTX..Now I have no loyalty for no CEO after 4000-1..2nd time better be better than the first..and it will be..for I believe its all uphill if you believe that $ 4 bucks will turn into at least $37 as its projected! We are going to trust LA only if he gets the tech to market..To help the people suffering from lower lumbar pain..then Onward with the Brown Edipose Fat Cells for Thermo Stem Obesity/diabeties..Cardio Vascular /heart ailment sufferors..Money comes to us if the tech gets FDA Approvals after Clinical Trials=then Revenue comes..We need Money..Lots..for that to happen..and LA told ? he has Funding..45 million for phase 3 BRTX trials would mean that this company is greatly undervalued at $ 4 bucks right now..i am sure he has it lined up..but when will he tell us? the Great thing is that All the management has been buying share thuout..so thats a Big Plus that they want to get filthy rich as we proceed to Revenue/FDA Approvals..People totalling 99 could report that their pain is gone..or lessened greatly because of the BRTX-100..Huge things could follow..I believe The tech works=Money!
Followers
|
481
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
63376
|
Created
|
11/16/07
|
Type
|
Free
|
Moderators |
We will need to obtain a significant amount of financing to initiate and complete our clinical trials and implement our business plan.
Since our inception, we have not generated revenues from our operations and have funded our operations through the sale of our equity securities and debt securities. The implementation of our business plan, as discussed in this prospectus under the caption “Business,” will require the receipt of sufficient equity and/or debt financing to purchase necessary equipment, technology and materials, fund our clinical trials and other research and development efforts and otherwise fund our operations. We anticipate that we will require approximately $12,000,000 in financing to complete a Phase 2 clinical trial using BRTX-100. We anticipate that we will require approximately $45,000,000 in further additional funding to complete our clinical trials using BRTX-100 (assuming the receipt of no revenues). We will also require a substantial amount of additional funding to implement our other programs described in this prospectus under the caption “Business,” including our metabolic ThermoStem Program, and fund general operations. The net proceeds of this offering will not be sufficient to satisfy the foregoing needs. No assurance can be given that the anticipated amounts of required funding are correct or that we will be able to accomplish our goals within the timeframes projected. In addition, no assurance can be given that we will be able to obtain any required financing on commercially reasonable terms or otherwise. In the event we do not obtain the financing required for the above purposes, we may have to curtail our development, marketing and promotional activities, which would have a material adverse effect on our business, financial condition and results of operations, and ultimately we could be forced to discontinue our operations and liquidate.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |